Zydus Lifesciences Limited
ZYDUSLIFE
株式のランク
#1754
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
株価
$12.30
時価総額
$12.27B
変化（1日）
0.06%
変化（1年）
8.33%
国
IN
取引 Zydus Lifesciences Limited (ZYDUSLIFE)
カテゴリー
Healthcare
Zydus Lifesciences Limited（ZYDUSLIFE）の配当利回りの履歴
Zydus Lifesciences Limited（銘柄コード: ZYDUSLIFE）の配当利回り（TTM）は2024-03-31時点で0.61%です。
過去5年間の平均配当利回り: 0.51%
過去5年間の平均配当利回り: 0.51%
Zydus Lifesciences Limited（ZYDUSLIFE）の2004から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.09% | -73.53% |
| 2025 | 0.34% | -44.26% |
| 2024 | 0.61% | 12.96% |
| 2023 | 0.54% | -48.08% |
| 2022 | 1.04% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 3.13% | 206.86% |
| 2019 | 1.02% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 0.72% | -59.55% |
| 2016 | 1.78% | 242.31% |
| 2015 | 0.52% | -28.77% |
| 2014 | 0.73% | -27.72% |
| 2013 | 1.01% | 23.17% |
| 2012 | 0.82% | 30.16% |
| 2011 | 0.63% | 350.00% |
| 2010 | 0.14% | -92.67% |
| 2009 | 1.91% | -32.98% |
| 2008 | 2.85% | 182.18% |
| 2007 | 1.01% | 65.57% |
| 2006 | 0.61% | -35.11% |
| 2005 | 0.94% | 224.14% |
| 2004 | 0.29% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
